Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells

Despite rapid advances in chemotherapy and surgical resection strategies, pancreatic cancer remains the fourth leading cause of cancer related deaths in the United States with a 5-year survival rate of less than 5%. Therefore, novel therapeutic agents for the prevention and treatment of pancreatic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongwei, Zhou, Yinan, Zhou, Haoxin, Jia, Guang, Liu, Ji, Han, Bing, Cheng, Zhuoxin, Jiang, Hongchi, Pan, Shangha, Sun, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429499/
https://www.ncbi.nlm.nih.gov/pubmed/22952775
http://dx.doi.org/10.1371/journal.pone.0043826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429499/
https://www.ncbi.nlm.nih.gov/pubmed/22952775
http://dx.doi.org/10.1371/journal.pone.0043826

Ejemplares similares